COc1cc2c3c4c1OCc1c5c(cc(c1-4)CC3[N+](C)(C)CC2)OCO5.[Cl-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?